ASCO 2026: Highlights and analysis

Yoga improves mood, fatigue, and insomnia in cancer survivors following treatment

Abemaciclib shows benefit in dedifferentiated liposarcoma

Denikitug shows immune activation and early anti-tumour activity in advanced solid tumour

Zedoresertib plus lunresertib shows promising tumour shrinkage in CCNE1-amplified and FBXW7-mutant cancers

Dual integrin inhibitor plus pembrolizumab shows durable responses in ICI-resistant solid tumours

Oral molecular glue degrader with or without spartalizumab shows immune activation and tumour control in solid tumours

ZL-1310 shows promising activity in DLL3-positive neuroendocrine carcinomas

Customised colorectal cancer early diagnosis programme can identify advanced adenomas and early-stage cancer

ESMO 2025: Highlights and analysis

Dose escalation of RG6344 demonstrates safety and promising activity in BRAF V600E solid tumours

ASCO 2025: Developments in the treatment of soft tissue sarcoma